Bioavailability 30-40%. Terminal half-life in children (6 months - 16 years) is 55 - 65 h [Stevens 1997, Jacobs 2005].
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Bacterial infections |
|---|
|
| Streptococcal pharyngitis |
|---|
|
| Chlamydia trachomatis |
|---|
| Prophylaxis after a tick bite |
|---|
| Early localized Lyme disease (erythema migrans or lymphocytoma) |
|---|
| Maintenance therapy for infection with P. aeruginosa in cystic fibrosis |
|---|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Mild gastrointestinal disorders often occur on oral administration.
After using Azithromycin in neonates (within the first 42 days after birth) cases of infantile hypertrophic pylorus stenosis were reported.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Adjust dose in children with reduced hepatic function.
The suspension and the tablets can be taken with food if required. After taking the suspension, a bitter aftertaste can be avoided by drinking fruit juice immediately after taking it.
Macrolid use by children during the first 2 weeks after birth is associated with a severely elevated risk of pyloric stenosis (relative risk – RR – of 29.8). Use of macrolides by children aged between 14 and 120 days triples the risk (RR = 3.24). For that reason, azithromycin should be prescribed with caution for children aged up to 4 months. Inform parents and caregivers to contact the doctor in case of persistent vomiting and irritation when feeding.
The efficacy and safety of prophylaxis against Mycobacterium avium intracellular complex (MAC) infections in children have not been determined.
The quantity of data available about use in children aged < 1 year is limited.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Macrolides | ||
|---|---|---|
| J01FA09 | ||
| Lincosamides | ||
|---|---|---|
| J01FF01 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.